Medical insurer launches cover with "pioneering treatments"
According to the insurer the policy offers treatments not available on the NHS or in the UK at international medical facilities.
Virtual insurer SecurityTrust has launched MediVISA a medical insurance plan covering cancer, heart diseases, neurological conditions and other illnesses.
According to the firm the product, which is available to all brokers, offers treatment not available on the NHS or in the UK at international medical facilities with pioneering therapies.
Underwritten at Lloyd’s of London, the product gives policyholders and their dependents access to “the latest and most advanced treatments, therapies and
Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.
To access these options, along with all other subscription benefits, please contact info@insuranceage.co.uk.
You are currently unable to print this content. Please contact info@insuranceage.co.uk to find out more.
You are currently unable to copy this content. Please contact info@insuranceage.co.uk to find out more.
Copyright Infopro Digital Limited. All rights reserved.
You may share this content using our article tools. Printing this content is for the sole use of the Authorised User (named subscriber), as outlined in our terms and conditions - https://www.infopro-insight.com/terms-conditions/insight-subscriptions/
If you would like to purchase additional rights please email info@insuranceage.co.uk
Copyright Infopro Digital Limited. All rights reserved.
You may share this content using our article tools. Copying this content is for the sole use of the Authorised User (named subscriber), as outlined in our terms and conditions - https://www.infopro-insight.com/terms-conditions/insight-subscriptions/
If you would like to purchase additional rights please email info@insuranceage.co.uk
Most read
- Zurich strikes five-year capacity deal with MGA Freedom Services
- Pen inks £150m social housing capacity deal with SiriusPoint
- RSA and NIG brands to become one next year but undecided on name